Concepts (137)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 11 | 2022 | 483 | 3.120 |
Why?
|
| Chlamydophila pneumoniae | 8 | 2017 | 22 | 2.290 |
Why?
|
| Chlamydia Infections | 7 | 2018 | 79 | 1.930 |
Why?
|
| Chlamydia trachomatis | 4 | 2021 | 60 | 1.410 |
Why?
|
| Respiratory Tract Infections | 3 | 2018 | 85 | 1.240 |
Why?
|
| Chlamydophila Infections | 3 | 2017 | 6 | 1.230 |
Why?
|
| Immunoglobulin E | 4 | 2013 | 81 | 1.160 |
Why?
|
| Chlamydia | 5 | 2013 | 11 | 1.120 |
Why?
|
| Neutrophils | 2 | 2018 | 390 | 0.720 |
Why?
|
| Houseflies | 1 | 2021 | 1 | 0.710 |
Why?
|
| Trachoma | 1 | 2021 | 3 | 0.710 |
Why?
|
| Respiratory System | 2 | 2011 | 46 | 0.670 |
Why?
|
| Macrolides | 2 | 2017 | 37 | 0.630 |
Why?
|
| Bronchoalveolar Lavage Fluid | 5 | 2018 | 91 | 0.610 |
Why?
|
| Histamine | 1 | 2018 | 21 | 0.580 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 2018 | 21 | 0.570 |
Why?
|
| Antibody Specificity | 3 | 2013 | 102 | 0.550 |
Why?
|
| Respiratory Sounds | 1 | 2016 | 21 | 0.480 |
Why?
|
| Nasopharynx | 1 | 2015 | 21 | 0.460 |
Why?
|
| Mycoplasma | 2 | 2011 | 6 | 0.440 |
Why?
|
| Antibodies, Bacterial | 2 | 2012 | 181 | 0.430 |
Why?
|
| Microbiota | 1 | 2015 | 168 | 0.380 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2012 | 7 | 0.380 |
Why?
|
| Child | 8 | 2024 | 4606 | 0.370 |
Why?
|
| Ureaplasma Infections | 1 | 2011 | 1 | 0.360 |
Why?
|
| Ureaplasma | 1 | 2011 | 2 | 0.360 |
Why?
|
| Mycoplasma Infections | 1 | 2011 | 4 | 0.350 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2012 | 127 | 0.350 |
Why?
|
| Interleukin-8 | 1 | 2010 | 95 | 0.330 |
Why?
|
| Phenotype | 1 | 2013 | 1231 | 0.310 |
Why?
|
| Polymerase Chain Reaction | 3 | 2021 | 513 | 0.280 |
Why?
|
| Caveolins | 2 | 2004 | 7 | 0.270 |
Why?
|
| Plateletpheresis | 1 | 2006 | 6 | 0.250 |
Why?
|
| Humans | 20 | 2024 | 64935 | 0.250 |
Why?
|
| HeLa Cells | 3 | 2004 | 541 | 0.250 |
Why?
|
| Blood Component Removal | 1 | 2006 | 17 | 0.250 |
Why?
|
| DNA, Bacterial | 3 | 2012 | 261 | 0.240 |
Why?
|
| Infant, Newborn | 4 | 2012 | 1414 | 0.220 |
Why?
|
| Bronchoscopy | 2 | 2019 | 88 | 0.220 |
Why?
|
| Mice, Inbred BALB C | 2 | 2018 | 869 | 0.220 |
Why?
|
| Infant | 4 | 2012 | 1683 | 0.210 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2004 | 44 | 0.210 |
Why?
|
| Glycolipids | 1 | 2004 | 44 | 0.210 |
Why?
|
| Child, Preschool | 4 | 2012 | 2052 | 0.200 |
Why?
|
| Complement System Proteins | 1 | 2004 | 110 | 0.200 |
Why?
|
| Disease Outbreaks | 1 | 2024 | 110 | 0.200 |
Why?
|
| Cohort Studies | 4 | 2012 | 2612 | 0.200 |
Why?
|
| Steroids | 1 | 2022 | 55 | 0.190 |
Why?
|
| Blood Proteins | 1 | 2022 | 84 | 0.190 |
Why?
|
| Adolescent | 5 | 2012 | 6292 | 0.180 |
Why?
|
| Cytokines | 2 | 2018 | 951 | 0.180 |
Why?
|
| Arthritis, Reactive | 1 | 2021 | 1 | 0.180 |
Why?
|
| Sanitation | 1 | 2021 | 6 | 0.180 |
Why?
|
| Animals | 6 | 2021 | 21287 | 0.170 |
Why?
|
| Chronic Disease | 2 | 2016 | 741 | 0.170 |
Why?
|
| Leukocytes | 2 | 2013 | 105 | 0.160 |
Why?
|
| Anti-Bacterial Agents | 3 | 2017 | 795 | 0.150 |
Why?
|
| Mice | 4 | 2018 | 11086 | 0.150 |
Why?
|
| Histidine Decarboxylase | 1 | 2018 | 1 | 0.150 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 2282 | 0.140 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 449 | 0.130 |
Why?
|
| Inflammation Mediators | 1 | 2018 | 179 | 0.130 |
Why?
|
| Young Adult | 3 | 2012 | 4793 | 0.130 |
Why?
|
| Adult | 5 | 2024 | 17307 | 0.130 |
Why?
|
| Female | 8 | 2013 | 33917 | 0.130 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 765 | 0.130 |
Why?
|
| Blood Donors | 2 | 2006 | 22 | 0.120 |
Why?
|
| Pneumonia, Bacterial | 1 | 2017 | 90 | 0.120 |
Why?
|
| Inflammation | 1 | 2022 | 1186 | 0.120 |
Why?
|
| Male | 7 | 2012 | 30942 | 0.110 |
Why?
|
| Mediastinum | 1 | 2013 | 28 | 0.100 |
Why?
|
| Ovalbumin | 1 | 2013 | 108 | 0.100 |
Why?
|
| Animals, Newborn | 1 | 2013 | 239 | 0.100 |
Why?
|
| Lymph Nodes | 1 | 2013 | 231 | 0.090 |
Why?
|
| Species Specificity | 2 | 2011 | 339 | 0.090 |
Why?
|
| Halobacterium | 1 | 2012 | 1 | 0.090 |
Why?
|
| Toll-Like Receptor 5 | 1 | 2012 | 11 | 0.090 |
Why?
|
| Immune Sera | 1 | 2012 | 35 | 0.090 |
Why?
|
| RNA, Messenger | 1 | 2018 | 1576 | 0.090 |
Why?
|
| Azithromycin | 1 | 2012 | 34 | 0.090 |
Why?
|
| Interleukin-12 | 1 | 2012 | 127 | 0.090 |
Why?
|
| Ureaplasma urealyticum | 1 | 2011 | 1 | 0.090 |
Why?
|
| Mycoplasma hominis | 1 | 2011 | 2 | 0.090 |
Why?
|
| Mycoplasma pneumoniae | 1 | 2011 | 3 | 0.090 |
Why?
|
| Mycoplasma genitalium | 1 | 2011 | 3 | 0.090 |
Why?
|
| Bacterial Vaccines | 1 | 2012 | 79 | 0.090 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2012 | 203 | 0.090 |
Why?
|
| Cloning, Molecular | 1 | 2012 | 384 | 0.090 |
Why?
|
| Interleukin-6 | 1 | 2012 | 323 | 0.080 |
Why?
|
| DNA, Ribosomal | 1 | 2010 | 31 | 0.080 |
Why?
|
| New York City | 1 | 2010 | 93 | 0.080 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2012 | 350 | 0.080 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2010 | 105 | 0.080 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 710 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 2 | 2008 | 401 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 603 | 0.080 |
Why?
|
| T-Lymphocytes | 1 | 2013 | 1004 | 0.070 |
Why?
|
| Case-Control Studies | 1 | 2012 | 1138 | 0.070 |
Why?
|
| Cell Line | 1 | 2012 | 2020 | 0.070 |
Why?
|
| Prevalence | 1 | 2012 | 1439 | 0.070 |
Why?
|
| Caveolin 1 | 2 | 2004 | 10 | 0.070 |
Why?
|
| Blood Preservation | 1 | 2006 | 6 | 0.060 |
Why?
|
| Platelet Transfusion | 1 | 2006 | 11 | 0.060 |
Why?
|
| Blood Specimen Collection | 1 | 2006 | 20 | 0.060 |
Why?
|
| Proteins | 1 | 2012 | 764 | 0.060 |
Why?
|
| Automation | 1 | 2006 | 55 | 0.060 |
Why?
|
| Pregnancy | 1 | 2013 | 2372 | 0.060 |
Why?
|
| Biomarkers | 1 | 2012 | 1476 | 0.060 |
Why?
|
| Treatment Outcome | 1 | 2017 | 5775 | 0.060 |
Why?
|
| Safety | 1 | 2006 | 143 | 0.060 |
Why?
|
| Tissue Culture Techniques | 1 | 2005 | 33 | 0.060 |
Why?
|
| Caveolin 2 | 1 | 2004 | 2 | 0.050 |
Why?
|
| Massachusetts | 1 | 2010 | 2141 | 0.050 |
Why?
|
| Vacuoles | 1 | 2004 | 31 | 0.050 |
Why?
|
| Sensation Disorders | 1 | 2024 | 23 | 0.050 |
Why?
|
| Guinea Pigs | 1 | 2004 | 86 | 0.050 |
Why?
|
| Golgi Apparatus | 1 | 2004 | 65 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2004 | 233 | 0.050 |
Why?
|
| Virulence | 1 | 2004 | 199 | 0.050 |
Why?
|
| Microscopy, Confocal | 1 | 2004 | 240 | 0.050 |
Why?
|
| Caveolae | 1 | 2003 | 3 | 0.050 |
Why?
|
| Membrane Microdomains | 1 | 2003 | 51 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2004 | 610 | 0.050 |
Why?
|
| Eukaryotic Cells | 1 | 2003 | 57 | 0.050 |
Why?
|
| Middle Aged | 2 | 2012 | 18203 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2008 | 3305 | 0.040 |
Why?
|
| Rats | 1 | 2004 | 1989 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2004 | 2187 | 0.040 |
Why?
|
| Aging | 1 | 2024 | 763 | 0.040 |
Why?
|
| Brain | 1 | 2024 | 1600 | 0.030 |
Why?
|
| Aged | 1 | 2012 | 14917 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2006 | 662 | 0.010 |
Why?
|
| Nystatin | 1 | 2003 | 3 | 0.010 |
Why?
|
| Filipin | 1 | 2003 | 3 | 0.010 |
Why?
|
| Host-Parasite Interactions | 1 | 2003 | 61 | 0.010 |
Why?
|
| Cholesterol | 1 | 2003 | 261 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 856 | 0.010 |
Why?
|